Paychex, Inc. Form 10-Q Summary
Business context and reporting period
Paychex provides human capital management, payroll, HR, benefits, insurance, and PEO solutions primarily to small and medium-sized businesses. The company reports as one segment, with operations principally in the United States and additional operations in parts of Europe and India. This filing covers the three months ended August 31, 2022, Paychex’s fiscal 2023 first quarter, compared with the three months ended August 31, 2021.
Financial performance and key metrics
| Metric | Q1 FY2023 | Q1 FY2022 | Change |
|---|---|---|---|
| Management Solutions revenue | $905.5 million | $805.5 million | 12% |
| PEO and Insurance Solutions revenue | $282.8 million | $262.9 million | 8% |
| Total service revenue | $1,188.3 million | $1,068.4 million | 11% |
| Interest on funds held for clients | $17.9 million | $14.5 million | 24% |
| Total revenue | $1,206.2 million | $1,082.9 million | 11% |
| Operating income | $495.6 million | $442.9 million | 12% |
| Net income | $379.2 million | $333.6 million | 14% |
| Diluted EPS | $1.05 | $0.92 | 14% |
| Operating margin | 41.1% | 40.9% | 20 basis points |
| Effective tax rate | 22.9% | 24.9% | Down 200 basis points |
| EBITDA | $539.7 million | $498.6 million | 8% |
Management attributed revenue growth to increased client and worksite employee counts, price realization, higher product penetration, strong demand for HR, retirement, and time-and-attendance solutions, expanded ancillary HCM services, and higher PEO health insurance revenue. Expense growth was driven by higher headcount and wage rates, increased health insurance enrollment, and other costs supporting business growth.
Adjusted net income was $371.9 million versus $323.2 million, and adjusted diluted EPS was $1.03 versus $0.89. These are non-GAAP measures adjusted for excess tax benefits from employee stock-based compensation.
Cash flow, liquidity, debt, and investments
- Cash provided by operating activities was $364.3 million, compared with $385.6 million in the prior-year quarter.
- Investing activities provided $1.223 billion, primarily reflecting net sales and maturities of available-for-sale securities, including sales of variable-rate demand notes.
- Financing activities used $809.7 million, including $507.9 million for the net change in client fund obligations and $284.6 million of dividends paid.
- Cash, restricted cash, and equivalents increased to $1.706 billion from $928.4 million at the beginning of the quarter.
- Cash and cash equivalents were $1.184 billion at August 31, 2022. Corporate investments totaled $49.7 million, excluding funds held for clients.
- Total short-term and long-term borrowings, net of debt issuance costs, were $808.1 million, consisting primarily of approximately $800 million of unsecured fixed-rate senior notes and $10.3 million of short-term borrowings.
- Credit facilities totaled $2.0 billion, of which $10.3 million was outstanding and approximately $1.990 billion was available. The company was in compliance with applicable covenants.
- Standby letters of credit totaled $140.2 million, with no amounts outstanding.
- Funds held for clients were $3.136 billion, matched by client fund obligations of $3.311 billion. These balances vary with the timing of client collections and remittances.
The investment portfolio had $2.725 billion of available-for-sale securities at fair value and $175.6 million of net unrealized losses, compared with $136.3 million at May 31, 2022. Management attributed the losses primarily to higher interest rates, stated that the securities were not impaired for credit reasons, and did not expect to be required to sell them before recovery or maturity.
Material changes versus the prior comparable period
- Total revenue increased 11%, while operating income increased 12% and net income increased 14%.
- Operating margin improved modestly to 41.1% from 40.9%, as revenue growth exceeded expense growth.
- Interest income benefited from higher average investment balances and higher interest rates; the combined average yield increased to 1.7% from 1.1%.
- Operating cash flow declined by $21.3 million, primarily because of cash outflows related to temporary staffing client funding and other working-capital changes.
- Dividends paid increased 20% to $284.6 million, reflecting an increase in the quarterly dividend from $0.66 to $0.79 per share.
- Net unrealized investment losses increased by $39.3 million from May 31, 2022, reflecting market interest-rate movements.
- No shares were repurchased during the quarter. The company had $327.1 million remaining under its $400 million repurchase authorization.
Outlook, risks, contingencies, and unusual items
Management stated that cash, restricted cash, corporate investments, projected operating cash flows, and available financing should support operations, capital purchases, share repurchases, and dividend payments for the foreseeable future. The company expects its total investment portfolio to average approximately $6.0 billion for fiscal 2023, with roughly half invested in short-term securities and variable-rate demand notes and half in available-for-sale securities.
Management estimates that a 25-basis-point change in short-term interest rates would affect after-tax earnings by approximately $4.5 million to $5.0 million over twelve months. A hypothetical 25-basis-point increase in longer-term rates could reduce the fair value of the available-for-sale portfolio by approximately $20 million to $25 million, with the effect generally recorded in accumulated other comprehensive income rather than current earnings unless credit impairment occurs.
- Key risks include cybersecurity and data privacy incidents, technology or software defects, third-party service disruptions, business-continuity failures, client credit losses, PEO co-employment and insurance claims exposure, changing insurance rates and claim trends, regulatory changes, litigation, inflation, labor availability, and macroeconomic weakness affecting small and medium-sized business clients.
- Workers’ compensation and health insurance reserves involve actuarial estimates and could change materially because of legal, economic, and claims developments.
- The company had approximately $7.6 million of commitments to purchase capital assets and maximum remaining commitments of approximately $11.0 million under venture capital fund arrangements.
- Management believes outstanding legal matters will not materially affect financial position or results, but acknowledges that adverse resolutions could have a material impact in a future period.
- No goodwill or intangible-asset impairment was recorded. The company adopted a government-assistance disclosure standard without material impact.
Important facts for investors to verify
- Confirm the sustainability of double-digit revenue growth, particularly Management Solutions growth and revenue per client.
- Assess the sensitivity of future interest income and accumulated other comprehensive income to further interest-rate increases.
- Review the liquidity and investment risks associated with client funds, available-for-sale securities, and the $175.6 million unrealized loss position.
- Monitor operating cash flow, temporary staffing receivables, client fund obligations, and the timing of payroll-tax and employee remittances.
- Evaluate PEO workers’ compensation and health insurance reserves, including potential changes in claims trends and actuarial estimates.
- Verify dividend and share-repurchase capacity against future earnings, cash flow, and capital needs.
- Confirm that debt and credit-facility covenants remain satisfied and that available financing remains accessible under changing market conditions.